What Echo Measurements Identify High-Risk Heart Failure Patients and Necessitate Flow-Reduction Surgery
Echocardiography (2D echo) is key for identifying patients at high risk of high-output heart failure (HOHF) caused by vascular access. Clinicians use specific flow ratios, cardiac measurements, and pressure indicators to monitor and manage these patients.
Key Hemodynamic Ratios and Flow Markers
The most important marker of cardiac risk is how vascular access flow (Qa) compares to the body’s total cardiac output (CO).
- Qa/CO Ratio:
When vascular access flow represents more than 20% to 30% of total cardiac output (Qa/CO > 0.2 or 0.3), it is a recognized predictive marker for acute heart failure risk. - Cardiac Output (CO):
Absolute high cardiac output (e.g., 10.1 L/min in some clinical cases) is a major indicator, especially when it significantly decreases (e.g., by 3 L/min or more) during temporary manual occlusion of the fistula.
Structural Measurements of Cardiac Remodeling
Chronic exposure to high-flow access leads to structural changes that echo can quantify:
- Left Ventricular Mass Index (LVMI):
Increased LV mass and size are hallmarks of access-related cardiac strain. Studies show that ligating a high-flow access can significantly reduce LV mass (e.g., a mean reduction of 22.1 g). - Ventricular Volumes and Diameters:
High-risk patients often show increased left ventricular end-diastolic diameter (LVEDD) and increased end-diastolic and end-systolic volumes. - Atrial and Right Ventricular Dilatation:
Enlargement of the atrial chamber and right ventricular (RV) dilatation are critical signs of volume overload and maladaptive remodeling.
Functional and Pressure Indicators
Beyond structural changes, echo evaluates how the heart is functioning under the increased workload:
- Right Ventricular Longitudinal Strain:
A specialized measurement used to monitor high-flow AV access and detect early RV dysfunction. - Systolic Pulmonary Arterial Pressure (PAP):
Elevated PAP indicates pulmonary hypertension, a common complication in high-risk HOHF patients. - Diastolic Dysfunction:
High-flow access can contribute to diastolic dysfunction, monitored via echo to assess the heart’s ability to relax and fill.
Clinical Application
Experts recommend obtaining a baseline 2D echo within the first year after a transplant or when access is created, to serve as a reference. If a patient develops symptoms such as shortness of breath or reduced exercise tolerance and the Qa is high (usually 1.5–2.0 L/min or more), these echo findings help determine whether flow-reduction surgery or access closure is needed to prevent long-term harm.
